FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy
Clinical trial NCT04491084 · TERMINATED
Trial details
- NCT number
- NCT04491084
- Sponsor
- Albert Einstein College of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-08-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.